Top headlines: Astra booster works against Omicron; Paym sees senior exits?

Business Standard brings you the top headlines on Thursday

AstraZeneca
Illustration: Reuters
BS Web Team New Delhi
2 min read Last Updated : Dec 23 2021 | 5:55 PM IST
Serum Institute on the up as Oxford study backs Astra booster for Omicron

A third booster shot of the AstraZeneca-Oxford Covid-19 vaccine, Vaxzevria, significantly boosts antibodies against the Omicron variant of the coronavirus, said the British drug company.

This brightens the scope for Serum Institute of India (SII) which makes Covishield, the domestic version of the Vaxzevria. Experts believe mixing vaccine shots may give better results in boosting immunity. Read more

IOC to invest Rs 9,028 crore for setting up a new crude oil pipeline

Indian Oil Corporation (IOC) will set up a new crude oil pipeline that will run from Mundra in Gujarat to Panipat in Haryana and will have a capacity of 17.5 million tonnes per annum (mmtpa).

A company statement IOC would build nine crude oil tanks of 60,000 kilolitres each at Mundra, increasing its operational and storage requirements in the country. Read more

PM Modi inaugurates 27 developmental projects worth Rs 2,095 cr in Varanasi

Prime Minister Narendra Modi on Thursday inaugurated or laid the foundation stones of 27 development projects worth Rs 2,095 crore in his Varanasi parliamentary constituency ahead of the Uttar Pradesh assembly elections.

This is Modi's second visit to the holy city within 10 days. Read more

China puts 13 million residents in lockdown ahead of Winter Games

China is redoubling efforts to control new virus outbreaks with a lockdown of the 13 million residents of the northern city of Xi'an following a spike in coronavirus cases.

The measure comes just weeks before the country hosts the Winter Olympics in Beijing, roughly 1,000 kilometers (6210 miles) to the west.  Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineIOCChina

Next Story